Financial statements Solfarma
Balance sheet data of SOLFARMA
Year
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|
Total assets | 363 752,56 | 187 458,08 | 7 675 134,99 | 10 801 481,27 |
A. Fixed assets | 88 303,56 | 92 247,56 | 6 176 485,61 | 10 341 051,11 |
B. Current assets | 275 449,00 | 95 210,52 | 1 498 649,38 | 460 430,16 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 |
Total liabilities | 363 752,56 | 187 458,08 | 7 675 134,99 | 10 801 481,27 |
A. Equity | 25 736,27 | 27 054,08 | -85,66 | -34 096,50 |
B. Liabilities and provisions for liabilities | 338 016,29 | 160 404,00 | 7 675 220,65 | 10 835 577,77 |
I. Long-term liabilities | 337 401,29 | 156 200,00 | 7 670 008,05 | - |
II. Short-term liabilities | 615,00 | 4 204,00 | 5 212,60 | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.